EBV-encoded dUTPase induces immune dysregulation: Implications for the pathophysiology of EBV-associated disease

Virology

Volumn 346, Issue 1, 2006, Pages 205-218

  Glaser, Ronald ^a,b,c   Litsky, Monica L ^b   Padgett, David A ^a,b,c   Baiocchi, Robert A ^a,c   Yang, Eric V ^a,b   Chen, Min ^b   Yeh, Peir En ^b   Green Church, Kari B ^b   Caligiuri, Michael A ^a,c   Williams, Marshall V ^a,c  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

Cancer; Cytokines; Epstein Barr virus; Monocytes macrophages; Tumor immunity

Indexed keywords

CD14 ANTIGEN; DEOXYURIDINE TRIPHOSPHATE PYROPHOSPHATASE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; RECOMBINANT ENZYME; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DNA REPLICATION; DRUG INHIBITION; DRUG MECHANISM; EPSTEIN BARR VIRUS; ILLNESS BEHAVIOR; IMMUNE DYSREGULATION; IN VITRO STUDY; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; UPREGULATION;

AMINO ACID SEQUENCE; CYTOKINES; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MACROPHAGES; MOLECULAR SEQUENCE DATA; MONOCYTES; PYROPHOSPHATASES; UP-REGULATION;

ANIMALIA; HUMAN HERPESVIRUS 4;

EID: 32844474149     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2005.10.034     Document Type: Article

References (53)

1. D.V. Ablashi, A.T. Huang, J.S. Pagano, G.R. Pearson, and C.S. Yang Epstein-Barr Virus and Human Disease 1990 Humana Press Clifton, NJ
2. P. Ahmad-Nejad, S. Mrabet-Dahbi, K. Breuer, M. Klotz, T. Werfel, U. Herz, K. Heeg, M. Neumaier, and H. Renz The toll-like receptor 2 R753Q polymorphism defines a subgroup of patients with atopic dermatitis having severe phenotype J. Allergy Clin. Immunol. 113 3 2004 565 567
3. R. Baer, A.T. Bankier, M.D. Biggin, P.L. Deininger, P.J. Farrell, T.J. Gibson, G. Hatfull, G.S. Hudson, S.C. Satchwell, and C. Seguin DNA sequence and expression of the B95-8 Epstein-Barr virus genome Nature 310 5974 1984 207 211
4. C. Blasig, C. Zietz, B. Haar, F. Neipel, S. Esser, N.H. Brockmeyer, E. Tschachler, S. Colombini, B. Ensoli, and M. Sturzl Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus 8 J. Virol. 71 10 1997 7963 7968
5. P. Brousset The Epstein-Barr virus infection relevant in lymphomagenesis? Hum. Pathol. 33 2 2002 143 145
6. D.R. Budiani, S. Hutahaean, S.M. Haryana, M. Soesatyo, and W. Sosroseno Interleukin-10 levels in Epstein-Barr virus-associated nasopharyngeal carcinoma J. Microbiol. Immunol. Infect. 35 4 2002 265 268
7. S. Carr, R. Aebersold, M. Baldwin, A. Burlingame, K. Clauser, and A. Nesvizhskii The need for guidelines in publication of peptide and protein identification data: working group on publication guidelines for peptide and protein identification data Mol. Cell. Proteomics 3 6 2004 531 533
8. Y.C. Cheng, J.Y. Chen, P.J. Hoffman, and R. Glaser Studies on the activity of DNase associated with the replication of the Epstein-Barr virus Virology 100 1980 334 338
9. M. D'Addario, A. Ahmad, A. Morgan, and J. Menezes Binding of the Epstein-Barr virus major envelope glycoprotein gp350 results in the upregulation of the TNF-alpha gene expression in monocytic cells via NF-kappaB involving PKC, PI3-K and tyrosine kinases J. Mol. Biol. 298 2000 765 778
10. J.H. Deng, Y.J. Zhang, X.P. Wang, and S.J. Gao Lytic replication- defective Kaposi's sarcoma-associated herpesvirus: potential role in infection and malignant transformation J. Virol. 78 20 2004 11108 11120
11. D.F. Dukers, P. Meij, M.B. Vervoort, W. Vos, R.J. Scheper, C.J. Meijer, E. Bloemena, and J.M. Middeldorp Direct immunosuppressive effects of EBV-encoded latent membrane protein 1 J. Immunol. 165 2 2000 663 670
12. L. Fayad, M.J. Keating, J.M. Reuben, S. O'Brien, B.-N. Lee, S. Lerner, and R. Kurzrock Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcome Blood 97 1 2001 256 263
13. D.F. Fiorentino, M.W. Bond, and T.R. Mosmann Two types of mouse T. Helper Cell IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones J. Exp. Med. 170 1989 2081 2095
14. D.F. Fiorentino, A. Zlotnik, T.R. Mosmann, M. Howard, and A. O'Garra IL-10 inhibits cytokine production by activated macrophages J. Immunol. 147 1991 3815 3822
15. J. Fleischmann, E. Kremmer, J.S. Greenspan, F.A. Grasser, and G. Niedobitek Expression of viral and human dUTPase in Epstein-Barr virus-associated diseases J. Med. Virol. 68 2002 568 573
16. R. Glaser, T. Ogino, J. Zimmerman Jr., and F. Rapp Thymidine kinase activity in Burkitt lymphoblastoid somatic cell hybrids after induction of the EB virus Proc. Soc. Exp. Biol. Med. 142 1973 1059 1062
17. R. Glaser, E.C. Strain, K. Tarr, J.E. Holliday, R.L. Donnerberg, and J.K. Kiecolt-Glaser Changes in Epstein-Barr virus antibody titers associated with aging Proc. Soc. Exp. Biol. Med. 179 1985 352 355
18. R. Glaser, G.R. Pearson, J.F. Jones, J. Hillhouse, S. Kennedy, H.Y. Mao, and J.K. Kiecolt-Glaser Stress-related activation of Epstein-Barr virus Brain Behav. Immun. 5 2 1991 219 232
19. R. Glaser, M.L. Litsky, D.A. Padgett, R.A. Baiocchi, E.V. Yang, M. Chen, P.-E. Yeh, N.G. Klimas, G.D. Marshall, T. Whiteside, R. Herberman, and M.V. Williams Stress-associated changes in the steady state expression of latent Epstein-Barr virus: implications for chronic fatigue syndrome and cancer Brain Behav. Immun. 19 2 2005 91 103
20. S.R. Goodman, C. Prezyna, and W.C. Benz Two Epstein-Barr virus-associated DNA polymerase activities J. Biol. Chem. 253 23 1978 8617 8628
21. J. Gosselin, J. Menezes, M. D'Addario, J. Hiscott, L. Flamand, G. Lamoureux, and D. Oth Inhibition of tumor necrosis factor-alpha transcription by Epstein-Barr virus Eur. J. Immunol. 21 1991 203 208
22. J. Gosselin, L. Flamand, M. D'Addario, J. Hiscott, and J. Menezes Infection of peripheral blood mononuclear cells by herpes simplex and Epstein-Barr viruses: differential induction of interleukin-6 and tumor necrosis factor alpha J. Clin. Invest. 89 1992 1849 1856
23. J. Gosselin, L. Flamand, M. D'Addario, J. Hiscott, I. Stefanescu, D.V. Ablashi, R.C. Gallo, and J. Menezes Modulatory effects of Epstein-Barr, herpes simplex and human herpes-6 viral infections and co-infections on cytokine synthesis: a comparative study J. Immunol. 149 1992 181 187
24. T. Gotleib-Stematsky, and R. Glaser Association of Epstein-Barr virus with neurologic diseases R. Glaser Gotlieb-Stematsky Human Herpesvirus Infections Clinical Aspects 1982 Marcel Dekker, Inc. New York, NY 169 204
25. B.E. Henry, R. Glaser, J. Hewetson, and D. O'Collaghan Expression of altered ribonucleotide reductase activity associated with the replication of the Epstein-Barr virus Virology 89 1978 262 271
26. M. Ho, R. Jaffe, G. Miller, M.K. Breinig, J.S. Dummer, L. Makowka, R.W. Atchison, F. Karrer, M.A. Nalesnik, and T.E. Starzl The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children Transplantation 45 4 1988 719 727
27. C.E. Ibanez, R. Schrier, P. Ghazal, C. Wiley, and J.A. Nelson Human cytomegalovirus productively infects primary differentiated macrophages J. Virol. 65 12 1991 6581 6588
28. H. Kanno, N. Naka, Y. Yasunaga, K. Luchi, S. Yamauchi, M. Hashimoto, and K. Aozasa Production of the immunosuppresive cytokine interleukin-10 by Epstein-Barr-virus-expressing pyothorax-associated lymphoma. Possible role in the development of overt lymphoma in immunocompetent hosts Am. J. Pathol. 150 1 1997 349 357
29. S.C. Klein, D. Kube, H. Abts, V. Diehl, and H. Tesch Promotion of IL8, IL10, TNF alpha and TNF beta production by EBV infection Leuk. Res. 20 8 1996 633 636
30. R. Kurzrock Cytokine deregulation in cancer Biomed. Pharmacother. 55 9-10 2001 543 547
31. R. Lai, S. O'Brien, T. Maushouri, A. Rogers, H. Kantarjian, M. Keating, and M. Albitar Prognostic value of plasma interleukin-6 levels in patients with chronic lymphocytic leukemia Cancer 95 5 2002 1071 1075
32. L.L. Laichalk, and D.A. Thorley-Lawson Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo J. Virol. 79 2 2005 1296 1307
33. M.G. Luciani, A. Stoppacciaro, G. Peri, A. Mantovani, and L.P. Ruco The monocyte chemotactic protein a (MCP-1) and interleukin 8 (IL-8) in Hodgkin's disease and in solid tumours Mol. Pathol. 51 5 1998 273 276
34. L.E. Mathes, R.G. Olsen, L.C. Hebebrand, E.A. Hoover, J.P. Schaller, P.W. Adams, and W.S. Nichols Immunosuppressive properties of a virion polypeptide, a 15,000-dalton protein from feline leukemia virus Cancer Res. 39 3 1979 950 955
35. R. Miller, R. Glaser, and F. Rapp Studies of an Epstein-Barr virus-induced DNA polymerase Virology 76 1977 494 502
36. I. Miyazaki, R.K. Cheung, and H.-M. Dosch Viral interleukin 10 is critical for the induction of B cell growth transformation by Epstein-Barr virus J. Exp. Med. 178 1993 439 447
37. A. Mori, S. Takao, J. Pradutkanchana, S. Kietthubthew, W. Mitarnun, and T. Ishida High tumor necrosis factor-alpha levels in patients with Epstein-Barr virus-associated peripheral T-cell proliferative disease/lymphoma Leuk. Res. 27 6 2003 493 498
38. T.R. Mosmann Properties and functions of interleukin-10 Adv. Immunol. 56 1994 1 26
39. M.P.N. Nair, R. Pottathil, E.P. Heimer, and S.A. Schwartz Immuno-regulatory activities of human immunodeficiency virus (HIV proteins): effect of HIV recombinant and synthetic peptides on immunoglobulin synthesis and proliferative responses by normal lymphocytes Proc. Natl. Acad. Sci. U. S. A. 85 1988 6498 6502
40. J.M. Nicholls, P. Sommer, E. Kremmer, K.S. Ong, K. Fung, J.M. Lee, M.H. Ng, and F.A. Grasser A new lytic antibody, 7D6, detects Epstein-Barr virus dUTPase in nonkeratinizing undifferentiated nasopharyngeal carcinomas Lab. Invest. 78 8 1998 1031 1032
41. L.A. O'Neill Signal transduction pathways activated by the IL-1 receptor/toll-like receptor superfamily Curr. Top. Microbiol. Immunol. 270 2002 47 61
42. D.A. Padgett, A.K. Hotchkiss, L.M. Pyter, R.J. Nelson, E. Yang, P.-E. Yeh, M. Litsky, M. Williams, and R. Glaser Epstein-Barr Virus-encoded dUTPase modulates immune function and induces sickness behavior in mice J. Med. Virol. 74 2004 442 448
43. T. Petrella, N. Yaziji, F. Colin, G. Rifle, F. Morlevat, L. Arnould, P. Fargeot, and O. Depret Implication of the Epstein-Barr virus in the progression of chronic lymphocytic leukaemia/small lymphocytic lymphoma to hodgkin-like lymphomas Anticancer Res. 17 1997 3907 3914
44. A.B. Rickinson, R.J. Murray, J. Brooks, H. Griffin, D.J. Moss, and M.G. Masucci T cell recognition of Epstein-Barr virus associated lymphomas Cancer Surv. 13 1992 53 80
45. W.K. Russell, Z.Y. Park, and D.H. Russell Proteolysis in mixed organic-aqueous solvent systems: applications for peptide mass mapping using mass spectrometry Anal. Chem. 73 2001 2682 2685
46. M. Savard, C. Belanger, M. Tardif, P. Gourde, L. Flamand, and J. Gosselin Infection of primary human monocytes by Epstein-Barr virus J. Virol. 74 6 2000 2612 2619
47. V. Sharma, and L. Zhang Interleukin-8 expression in AIDS-associated lymphoma B-cell lines Biochem. Biophys. Res. Commun. 282 2 2001 369 375
48. P. Sommer, E. Kremmer, S. Bier, S. Konig, P. Zalud, M. Zeppezauer, J.F. Jones, N. Mueller-Lantzsch, and F.A. Grasser Cloning and expression of the Epstein-Barr Virus encoded dUTPase: patients with acute, reactivated or chronic virus infection develop antibodies against the enzyme J. Gen. Virol. 77 Pt. 11 1996 2795 2805
49. N.M. Steven, N.E. Annels, A. Kumar, A.M. Leese, M.G. Kurilla, and A.B. Rickinson Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response J. Exp. Med. 185 9 1997 1605 1617
50. J.E. Tanner, C. Alfieri, T.A. Chatil, and F. Diaz-Mitoma Induction of interleukin-6 after stimulation of human B-cell CD21 by Epstein-Barr virus glycoproteins gp350 and gp220 J. Virol. 70 1996 570 575
51. R. Touitou, H. Arbach, C. Cochet, J. Feuillard, A. Martin, M. Raphael, and I. Joab Heterogeneous Epstein-Barr virus latent gene expression in AIDS-associated lymphomas and in type I Burkitt's lymphoma cell lines J. Gen. Virol. 84 2003 949 957
52. K.S. Voo, T. Fu, H.E. Heslop, M.K. Brenner, C.M. Rooney, and R.-F. Wang Identification of HLA-DP3-restricted peptides from EBNA1 recognized by CD4 (+) T cells Cancer Res. 62 24 2002 7195 7199
53. M.V. Williams, J.E. Holliday, and R. Glaser Induction of a deoxyuridine triphosphate nucleotidohdrolase activity in Epstein-Barr virus-infected cells Virology 142 1985 326 333